Biologics Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2025
WiseGuyRerports.com Presents “Global Biologics Outsourcing Market Size, Status and Forecast 2025” New Document to its Studies Database
This report studies the global Biologics Outsourcing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biologics Outsourcing market by companies, region, type and end-use industry.
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
In 2017, the global Biologics Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global top players, covered
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Innovent Biologics
Selexis
Lonza
Abzena
Adimab
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3328910-global-biologics-outsourcing-market-size-status-and-forecast-2025
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Antibody
Recombinant
Protein
Vaccines
Others
Market segment by Application, split into
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
The study objectives of this report are:
To study and forecast the market size of Biologics Outsourcing in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
Complete Report Details @ https://www.wiseguyreports.com/reports/3328910-global-biologics-outsourcing-market-size-status-and-forecast-2025
Table Of Contents:
1 Industry Overview of Biologics Outsourcing
1.1 Biologics Outsourcing Market Overview
1.1.1 Biologics Outsourcing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biologics Outsourcing Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Biologics Outsourcing Market by Type
1.3.1 Antibody
1.3.2 Recombinant
1.3.3 Protein
1.3.4 Vaccines
1.3.5 Others
1.4 Biologics Outsourcing Market by End Users/Application
1.4.1 Vaccine & Therapeutics Development
1.4.2 Blood & Blood Related Products Testing
1.4.3 Cellular and Gene Therapy
1.4.4 Other
2 Global Biologics Outsourcing Competition Analysis by Players
2.1 Biologics Outsourcing Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Boehringer Ingelheim
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.2 Catalent
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.3 GenScript
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.4 Innovent Biologics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.5 Syngene
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.6 Shanghai Medicilon
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.7 GL Biochem Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.8 GVK Biosciences Private
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.9 Horizon Discovery Group
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.10 Innovent Biologics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.11 Selexis
3.12 Lonza
3.13 Abzena
3.14 Adimab
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
This report studies the global Biologics Outsourcing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biologics Outsourcing market by companies, region, type and end-use industry.
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
In 2017, the global Biologics Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global top players, covered
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Innovent Biologics
Selexis
Lonza
Abzena
Adimab
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3328910-global-biologics-outsourcing-market-size-status-and-forecast-2025
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Antibody
Recombinant
Protein
Vaccines
Others
Market segment by Application, split into
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
The study objectives of this report are:
To study and forecast the market size of Biologics Outsourcing in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
Complete Report Details @ https://www.wiseguyreports.com/reports/3328910-global-biologics-outsourcing-market-size-status-and-forecast-2025
Table Of Contents:
1 Industry Overview of Biologics Outsourcing
1.1 Biologics Outsourcing Market Overview
1.1.1 Biologics Outsourcing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biologics Outsourcing Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Biologics Outsourcing Market by Type
1.3.1 Antibody
1.3.2 Recombinant
1.3.3 Protein
1.3.4 Vaccines
1.3.5 Others
1.4 Biologics Outsourcing Market by End Users/Application
1.4.1 Vaccine & Therapeutics Development
1.4.2 Blood & Blood Related Products Testing
1.4.3 Cellular and Gene Therapy
1.4.4 Other
2 Global Biologics Outsourcing Competition Analysis by Players
2.1 Biologics Outsourcing Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Boehringer Ingelheim
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.2 Catalent
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.3 GenScript
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.4 Innovent Biologics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.5 Syngene
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.6 Shanghai Medicilon
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.7 GL Biochem Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.8 GVK Biosciences Private
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.9 Horizon Discovery Group
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.10 Innovent Biologics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biologics Outsourcing Revenue (Million USD) (2013-2018)
3.11 Selexis
3.12 Lonza
3.13 Abzena
3.14 Adimab
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)